(19)
(11) EP 3 084 664 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
17.06.2020 Bulletin 2020/25

(45) Mention of the grant of the patent:
05.02.2020 Bulletin 2020/06

(21) Application number: 14818928.5

(22) Date of filing: 11.12.2014
(51) International Patent Classification (IPC): 
G16B 20/20(2019.01)
C12Q 1/68(2018.01)
G16B 25/30(2019.01)
(86) International application number:
PCT/EP2014/077473
(87) International publication number:
WO 2015/091225 (25.06.2015 Gazette 2015/25)

(54)

SYSTEMS AND METHODS FOR PREDICTING A SMOKING STATUS OF AN INDIVIDUAL

SYSTEME UND METHODEN ZUR BESTIMMUNG DES RAUCHERSTATUS

SYSTÈMES ET PROCÉDÉS POUR LA DÉTERMINATION DU STATUT DU FUMEUR


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 16.12.2013 US 201361916443 P

(43) Date of publication of application:
26.10.2016 Bulletin 2016/43

(73) Proprietor: Philip Morris Products S.A.
2000 Neuchâtel (CH)

(72) Inventors:
  • MARTIN, Florian
    2034 Peseux (CH)
  • TALIKKA, Marja
    1350 Orbe (CH)

(74) Representative: Ponder, William Anthony John et al
Reddie & Grose LLP The White Chapel Building 10 Whitechapel High Street
London E1 8QS
London E1 8QS (GB)


(56) References cited: : 
WO-A2-2013/032917
   
  • PHILIP BEINEKE ET AL: "A whole blood gene expression-based signature for smoking status", BMC MEDICAL GENOMICS, BIOMED CENTRAL LTD, LONDON UK, vol. 5, no. 1, 3 December 2012 (2012-12-03), page 58, XP021137778, ISSN: 1755-8794, DOI: 10.1186/1755-8794-5-58
  • RICARDO A. VERDUGO ET AL: "Graphical Modeling of Gene Expression in Monocytes Suggests Molecular Mechanisms Explaining Increased Atherosclerosis in Smokers", PLOS ONE, vol. 8, no. 1, 23 January 2013 (2013-01-23), page e50888, XP055188292, DOI: 10.1371/journal.pone.0050888
  • "Array-Based Gene Expression Analysis", www.illumina.com , 10 April 2013 (2013-04-10), XP002739403, Retrieved from the Internet: URL:https://web.archive.org/web/2013041019 2832/http://www.illumina.com/documents/pro ducts/datasheets/datasheet_gene_exp_analys is.pdf [retrieved on 2015-05-08]
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).